证券代码：603928 证券简称：兴业股份 公告编号：2024-021 苏州兴业材料科技股份有限公司 2023 年年度股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、 会议召开和出席情况 | 1、出席会议的股东和代理人人数 | 10 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 126,204,500 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | | | 份总数的比例（%） | 62.6014 | (四) 表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次股东大会由公司董事会召集，董事长王进兴先生主持。会议采用现场投 票和网络投票相结合的方式进行表决。会议的召开和表决符合《公司法》及《公 (一) 股东大会召开的时间：2024 年 05 月 20 日 (二) 股东大会召开的地点：苏州高新区浒关工业园道安路 15 号研发大楼会议 室 (三) 出席会议的普通股股东和恢复表决权的优先股股东 ...

北京市中伦（上海）律师事务所 关于苏州兴业材料科技股份有限公司 2023 年年度股东大会的 法律意见书 二〇二四年五月 法律意见书 北京市中伦（上海）律师事务所 关于苏州兴业材料科技股份有限公司 2023 年年度股东大会的 法律意见书 致：苏州兴业材料科技股份有限公司 苏州兴业材料科技股份有限公司（下称"公司"）2023 年年度股东大会（下 称"本次股东大会"）于 2024 年 5 月 20 日召开。北京市中伦（上海）律师事务所 （下称"本所"）接受公司的委托，指派佀荣天律师、许多律师（下称"本所律师"） 出席本次股东大会，根据《中华人民共和国公司法》（下称《公司法》）、《上市公 司股东大会规则（2022 年修订）》（下称《股东大会规则》）以及《苏州兴业材料 科技股份有限公司章程》（下称《公司章程》）的规定，对本次股东大会进行见证， 并出具本法律意见书。 在本法律意见书中，本所律师仅对本次股东大会的召集和召开程序、出席会 议人员的资格、召集人资格、会议表决程序以及表决结果是否符合《公司法》《股 东大会规则》以及《公司章程》的规定发表意见，并不对本次股东大会所审议的 提案内容以及这些提案所表述的事实或数据的真实 ...

证券代码：603928 证券简称：兴业股份 公告编号：2024-020 苏州兴业材料科技股份有限公司（以下简称"公司"）2023 年度业绩说明 会于 2024 年 05 月 14 日 15:00-16:00 通过上海证券交易所上证路演中心以网络 互动方式召开。公司已于 2024 年 04 月 26 日在上海证券交易所网站 (www.sse.com.cn)及指定披露媒体披露了《兴业股份关于召开 2023 年度业绩说 明会的公告》（公告编号：2024-013）。现将说明会召开情况公告如下： 一、本次业绩说明会召开情况 2024 年 05 月 14 日，公司董事长兼总经理王进兴先生、独立董事何前女士、 财务总监陆佳先生及董事会秘书蒋全志先生出席了本次业绩说明会。与投资者 进行互动交流和沟通，在信息披露允许的范围内就投资者普遍关注的问题进行 了回答。 二、本次业绩说明会投资者提出的主要问题（包括会前征集到的问题）及 公司的回复情况 问题 1、公司泰兴项目进展如何，什么时候能建设，什么时候能投产？ 答：尊敬的投资者，您好。公司泰兴项目进展可关注此前的进展公告及 2023 年年度报告。公司将协调各方力量，努力推动项目进展 ...

证券代码：603928 证券简称：兴业股份 公告编号：2024-018 苏州兴业材料科技股份有限公司 股票交易异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ●苏州兴业材料科技股份有限公司（以下简称"公司"）股票于 2024 年 5 月 7 日、5 月 8 日连续二个交易日收盘价格涨幅偏离值累计达 20%，根据《上海 证券交易所股票交易规则》的有关规定，属于股票交易异常波动情形。 ●公司对国产大飞机 C919 刹车片用浸渍树脂的销售显著微小，对 2023 年 年度营收贡献不到 20 万元，约占主营收入的 0.01%。敬请广大投资者注意市场 炒作风险。 ●公司 2023 年度实现营业收入 1,500,368,535.54 元，同比减少 16.06%； 实现归属于上市公司股东的净利润 75,942,003.10 元，同比减少 34.67%。公司 2024 年一季度实现营业收入 335,339,287.03 元，同比减少 8.05%；归属于上市 公司股东的净利润 15,770,766.94 元，同比减少 ...

证券代码：603928 证券简称：兴业股份 公告编号：2024-017 苏州兴业材料科技股份有限公司 股票交易风险提示公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ●苏州兴业材料科技股份有限公司（以下简称"公司"）股票于 2024 年 4 月 29 日、4 月 30 日、5 月 6 日连续三个交易日收盘价格涨幅偏离值累计达 20%， 根据《上海证券交易所股票交易规则》的有关规定，属于股票交易异常波动情 形。2024 年 5 月 7 日公司股价再次涨停。 敬请广大投资者注意二级市场交易 风险，理性决策，审慎投资。 （三）媒体报道、市场传闻、热点概念情况 ●公司对国产大飞机 C919 刹车片用浸渍树脂的销售显著微小，对 2023 年 年度营收贡献不到 20 万元，约占主营收入的 0.01%。敬请广大投资者注意市场 炒作风险。 ●公司 2023 年度实现营业收入 1,500,368,535.54 元，同比减少 16.06%； 实现归属于上市公司股东的净利润 75,942,003.10 元，同比减少 34.67 ...

1 苏州兴业材料科技股份有限公司 2023 年年度股东大会会议资料 （603928） 2024 年 5 月 | 2023 | 年年度股东大会须知 | | 3 | | --- | --- | --- | --- | | 2023 | 年年度股东大会会议议程 | | 5 | | 议案一 | 公司 2023 | 年度董事会工作报告 | 7 | | 议案二 | 公司 2023 | 年度监事会工作报告 | 13 | | 议案三 | 公司 2023 | 年度报告及摘要 | 17 | | 议案四 | 公司 2023 | 年度利润分配及资本公积金转增股本方案的议案 | 18 | | 议案五 | 关于授权董事会合理决定公司 | 2024 年中期利润分配方案的议案 | 19 | | 议案六 | 公司 2023 | 年度财务决算报告的议案 | 20 | | 议案七 | | 关于续聘会计师事务所的议案 | 22 | | 议案八 | 关于公司及控股子公司 2024 | 年度拟向金融机构申请授信额度的议案 | 23 | | 议案九 | | 关于公司使用自有资金进行现金管理的议案 | 24 | | 议案十 | 关于确认 2023 | 年度 ...

●经公司核查及向公司控股股东、实际控制人函证确认，不存在应披露而 未披露的重大信息。 ●公司董事会确认，公司日常经营活动正常，不存在影响公司股票交易价 格异常波动的重大事项。 一、股票交易异常波动的具体情况 截至 2024 年 5 月 6 日上海证券交易所交易收盘，公司股票于 2024 年 4 月 29 日、4 月 30 日、5 月 6 日连续三个交易日收盘价格涨幅偏离值累计达 20%， 根据《上海证券交易所股票交易规则》规定，属于股票交易异常波动情形。 二、公司关注并核实的相关情况 （一）生产经营情况 证券代码：603928 证券简称：兴业股份 公告编号：2024-016 苏州兴业材料科技股份有限公司 股票交易异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ●苏州兴业材料科技股份有限公司（以下简称"公司"）股票于 2024 年 4 月 29 日、4 月 30 日、5 月 6 日连续三个交易日收盘价格涨幅偏离值累计达 20%，根据《上海证券交易所股票交易规则》的有关规定，属于股票交易异常波 动情形 ...

Financial Performance - The company's operating revenue for Q1 2024 was CNY 335,339,287.03, representing a decrease of 8.05% compared to the same period last year[4]. - The net profit attributable to shareholders was CNY 15,770,766.94, down 20.98% year-on-year[4]. - Basic and diluted earnings per share were both CNY 0.08, reflecting a decline of 20.00% compared to the previous year[4]. - In Q1 2024, the company's net profit was CNY 15,770,766.94, a decrease of 20.98% compared to CNY 19,958,866.16 in Q1 2023[17]. - The operating profit for Q1 2024 was CNY 20,070,784.19, down from CNY 25,648,120.58 in the same period last year, reflecting a decline of 21.73%[17]. - The total revenue from sales of goods and services received in Q1 2024 was CNY 387,153,170.54, a decrease of 18.66% from CNY 476,318,230.66 in Q1 2023[20]. Cash Flow and Investments - The net cash flow from operating activities decreased significantly by 61.27%, primarily due to a reduction in cash received from sales[7]. - Cash flow from operating activities in Q1 2024 was CNY 38,054,332.16, a significant decrease of 61.24% from CNY 98,258,161.11 in Q1 2023[21]. - Total cash inflow from investment activities was CNY 50,763,874.80, compared to CNY 238,186,076.73 in Q1 2023, indicating a decline of 78.69%[21]. - The company reported a net cash outflow from investment activities of CNY 22,463,783.25 in Q1 2024, contrasting with a net inflow of CNY 44,715,831.07 in Q1 2023[21]. - The total cash and cash equivalents at the end of Q1 2024 were CNY 115,477,985.24, a decrease from CNY 133,843,726.64 at the end of Q1 2023[21]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,850,417,833.35, an increase of 0.64% from the end of the previous year[5]. - Total current assets as of March 31, 2024, amounted to ¥1,091,991,037.37, an increase of 1.12% from ¥1,074,868,051.12 at the end of 2023[13]. - Total assets reached ¥1,850,417,833.35 as of March 31, 2024, compared to ¥1,838,729,264.50 at the end of 2023, indicating a growth of 0.59%[15]. - Total liabilities decreased to ¥305,091,670.78 from ¥310,402,694.39, reflecting a reduction of 1.01%[14]. - Cash and cash equivalents increased to ¥118,619,775.25 from ¥104,432,403.13, representing a growth of 13.59%[12]. - Accounts receivable rose to ¥583,025,602.90, up from ¥574,382,495.95, indicating an increase of 1.27%[12]. - Inventory decreased to ¥81,187,782.95 from ¥88,157,629.88, a decline of 7.73%[12]. Profitability Metrics - Gross profit margin for Q1 2024 was approximately 4.99%, compared to 6.27% in Q1 2023[16]. - The company incurred a credit impairment loss of CNY -333,865.96 in Q1 2024, compared to CNY -441,833.53 in Q1 2023, showing an improvement of 24.48%[17]. Other Information - The company received government subsidies amounting to CNY 352,488.90 during the reporting period[6]. - Non-recurring gains and losses totaled CNY 702,513.78 after tax[6]. - The company did not report any new product developments or market expansion strategies during this quarter[11]. - The company did not report any net profit from subsidiaries prior to the merger in Q1 2024, consistent with the previous year[18].

Financial Performance - The company's operating revenue for 2023 was CNY 1,500,368,535.54, a decrease of 16.06% compared to CNY 1,787,335,261.45 in 2022[24]. - Net profit attributable to shareholders was CNY 75,942,003.10, down 34.67% from CNY 116,241,789.56 in the previous year[24]. - Basic earnings per share fell by 34.48% to CNY 0.38 from CNY 0.58 in 2022[26]. - The weighted average return on equity decreased by 2.77 percentage points to 5.03% from 7.80% in the previous year[26]. - The company achieved operating revenue of CNY 1.5 billion in 2023, a year-on-year decrease of 16.06%[51]. - The net profit attributable to the parent company was CNY 75.94 million, reflecting a decline of 34.67% year-on-year, mainly due to lower product prices leading to decreased sales revenue[51]. - Revenue from domestic operations reached ¥1,473,395,449.40, a decrease of 16.65% year-over-year, while gross margin increased by 0.07 percentage points to 14.73%[57]. - The total revenue from foreign operations was ¥7,724,930.63, showing a significant increase of 215.81% year-over-year, but gross margin decreased by 1.53 percentage points to 47.99%[57]. Cash Flow and Dividends - The company plans to distribute a cash dividend of 0.115 CNY per share, totaling 23,184,000 CNY, representing a cash dividend payout ratio of 30.53% for the year 2023[5]. - The net cash flow from operating activities increased significantly by 160.75% to CNY 250,773,283.80 from CNY 96,174,737.11 in 2022[25]. - The company has established a cash dividend policy that mandates a minimum cash dividend ratio of 80% for mature companies without significant capital expenditure plans[151]. - The company plans to distribute at least 10% of the annual distributable profit in cash, following the extraction of surplus reserves[148]. Risk Management - The company emphasizes the importance of risk awareness regarding forward-looking statements due to inherent uncertainties[6]. - The company has confirmed that there are no non-operating fund occupations by controlling shareholders or related parties[7]. - The company has detailed various risks and countermeasures in the management discussion and analysis section of the report[10]. - The company experienced a 16.10% decrease in accounts receivable balance, with a turnover rate of 2.38, indicating stable overall risk management[33]. - The company is exposed to international political and economic risks, which may affect the trade and pricing of petrochemical products[116]. - The company’s accounts receivable balance is high, posing operational funding management challenges and potential bad debt risks if major clients face financial difficulties[115]. Environmental Compliance - The company has maintained no major environmental violations or penalties during the reporting period[162]. - The company has implemented a comprehensive wastewater treatment process, including pre-treatment and biological treatment, ensuring compliance with discharge standards[170]. - The company has established an environmental self-monitoring plan, engaging qualified third-party monitoring agencies for wastewater, waste gas, and noise emissions[175]. - The company has committed to carbon reduction measures, including the use of steam heat to replace electric heating, contributing to lower CO2 emissions[179]. - The company has implemented emergency response plans for environmental incidents, with registrations completed in February and September 2022[174][175]. Research and Development - The company focuses on R&D of functional new materials, with main products including casting materials and specialty phenolic resins, which are essential for high-end components in various industries[40]. - The company has successfully developed bio-based environmentally friendly self-hardening furan resin and a new organic ester modified water glass bonding system, pushing these products to market[35]. - The company intends to increase R&D efforts in the specialty phenolic resin sector to penetrate the mid-to-high-end product market[108]. - Research and development expenses amounted to ¥47,909,291.45, representing 3.19% of total revenue, with a year-over-year decrease of 19.58%[65]. Corporate Governance - The board of directors and supervisory board guarantee the authenticity, accuracy, and completeness of the annual report[8]. - The company has established a robust internal governance structure, ensuring compliance with legal requirements and enhancing information disclosure practices[118]. - The company has a stable management team, with all key executives retaining their shareholdings[126]. - The company continues to prioritize independence in operations and governance, ensuring no conflicts with controlling shareholders[120]. - The board of directors has established specialized committees to enhance governance and oversight[138]. Market Position and Strategy - The company is positioned as a leader in the casting resin binder market, competing effectively against both domestic and foreign enterprises[78]. - The company has established stable long-term relationships with raw material suppliers to mitigate risks from price fluctuations[42]. - The company is actively seeking investment opportunities that align with its business, technology, and future development trends[108]. - The company is responding to government policies aimed at supporting the private economy, which may enhance future growth prospects[33]. Subsidiaries and Investments - The company has established six subsidiaries, including 100% owned subsidiaries and those with varying ownership stakes[102]. - The subsidiary Xingye Chemical reported total assets of 1.519 billion RMB and a net profit of 8.9826 million RMB for the reporting period[103]. - The company plans to invest a total of 3 billion RMB in a new project in Taixing Economic Development Zone, with funding sourced from its own or self-raised funds[99]. Shareholder Relations - The company emphasizes the protection of shareholder interests by enhancing governance structures and maintaining transparent communication with investors[181]. - The company has a three-year shareholder dividend return plan from 2021 to 2023, emphasizing stable returns to investors[146]. - The company has committed to repurchase all newly issued shares at the original IPO price within 60 days if there are any false statements or omissions in the prospectus that materially affect the issuance conditions[186].